CELLEBRITE DI LTD (CLBT) Stock Fundamental Analysis
USA - NASDAQ:CLBT - IL0011794802 - Common Stock
18.05 USD
-0.13 (-0.72%)
18.05 USD
0 (0%)
Taking everything into account, CLBT scores 5 out of 10 in our fundamental rating. CLBT was compared to 285 industry peers in the Software industry. CLBT has an excellent financial health rating, but there are some minor concerns on its profitability. CLBT is valied quite expensively at the moment, while it does show a decent growth rate.
1. Profitability
1.1 Basic Checks
In the past year CLBT was profitable.
In the past year CLBT had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: CLBT reported negative net income in multiple years.
CLBT had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
With a Return On Assets value of -19.17%, CLBT is not doing good in the industry: 70.88% of the companies in the same industry are doing better.
CLBT has a Return On Equity of -36.96%. This is in the lower half of the industry: CLBT underperforms 63.86% of its industry peers.
CLBT has a Return On Invested Capital of 10.23%. This is amongst the best in the industry. CLBT outperforms 86.32% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for CLBT is below the industry average of 11.90%.
The last Return On Invested Capital (10.23%) for CLBT is above the 3 year average (7.06%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -19.17% | ||
| ROE | -36.96% | ||
| ROIC | 10.23% |
ROA(3y)-9.14%
ROA(5y)-1.85%
ROE(3y)-54.72%
ROE(5y)N/A
ROIC(3y)7.06%
ROIC(5y)7.59%
1.3 Margins
CLBT has a better Operating Margin (14.16%) than 80.35% of its industry peers.
In the last couple of years the Operating Margin of CLBT has grown nicely.
Looking at the Gross Margin, with a value of 84.38%, CLBT belongs to the top of the industry, outperforming 91.93% of the companies in the same industry.
CLBT's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 14.16% | ||
| PM (TTM) | N/A | ||
| GM | 84.38% |
OM growth 3Y10.9%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.66%
GM growth 5Y1.3%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so CLBT is still creating some value.
CLBT has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, CLBT has more shares outstanding
There is no outstanding debt for CLBT. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
2.2 Solvency
An Altman-Z score of 8.02 indicates that CLBT is not in any danger for bankruptcy at the moment.
CLBT has a better Altman-Z score (8.02) than 78.95% of its industry peers.
There is no outstanding debt for CLBT. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | 8.02 |
ROIC/WACC1.09
WACC9.42%
2.3 Liquidity
CLBT has a Current Ratio of 1.96. This is a normal value and indicates that CLBT is financially healthy and should not expect problems in meeting its short term obligations.
With a Current ratio value of 1.96, CLBT perfoms like the industry average, outperforming 60.00% of the companies in the same industry.
A Quick Ratio of 1.92 indicates that CLBT should not have too much problems paying its short term obligations.
CLBT has a Quick ratio (1.92) which is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.96 | ||
| Quick Ratio | 1.92 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an nice 16.75% over the past year.
Looking at the last year, CLBT shows a very strong growth in Revenue. The Revenue has grown by 20.48%.
Measured over the past years, CLBT shows a quite strong growth in Revenue. The Revenue has been growing by 18.47% on average per year.
EPS 1Y (TTM)16.75%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%20%
Revenue 1Y (TTM)20.48%
Revenue growth 3Y17.68%
Revenue growth 5Y18.47%
Sales Q2Q%18.35%
3.2 Future
CLBT is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 12.94% yearly.
The Revenue is expected to grow by 15.18% on average over the next years. This is quite good.
EPS Next Y18.9%
EPS Next 2Y12.72%
EPS Next 3Y12.96%
EPS Next 5Y12.94%
Revenue Next Year17.63%
Revenue Next 2Y17.21%
Revenue Next 3Y17.04%
Revenue Next 5Y15.18%
3.3 Evolution
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 39.24, which means the current valuation is very expensive for CLBT.
Compared to the rest of the industry, the Price/Earnings ratio of CLBT indicates a somewhat cheap valuation: CLBT is cheaper than 61.40% of the companies listed in the same industry.
The average S&P500 Price/Earnings ratio is at 27.69. CLBT is valued slightly more expensive when compared to this.
CLBT is valuated quite expensively with a Price/Forward Earnings ratio of 33.83.
Compared to the rest of the industry, the Price/Forward Earnings ratio of CLBT is on the same level as its industry peers.
CLBT's Price/Forward Earnings ratio indicates a valuation a bit more expensive than the S&P500 average which is at 23.18.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 39.24 | ||
| Fwd PE | 33.83 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, CLBT is valued a bit cheaper than the industry average as 64.21% of the companies are valued more expensively.
Based on the Price/Free Cash Flow ratio, CLBT is valued a bit cheaper than 72.28% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 29.62 | ||
| EV/EBITDA | 50.36 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates CLBT does not grow enough to justify the current Price/Earnings ratio.
CLBT's earnings are expected to grow with 12.96% in the coming years. This may justify a more expensive valuation.
PEG (NY)2.08
PEG (5Y)N/A
EPS Next 2Y12.72%
EPS Next 3Y12.96%
5. Dividend
5.1 Amount
No dividends for CLBT!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
18.05
-0.13 (-0.72%)
Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)
Earnings (Next)
Inst Owners44.23%
Inst Owner Change0%
Ins Owners2.65%
Ins Owner ChangeN/A
Market Cap4.41B
Analysts84.29
Price Target24.14 (33.74%)
Short Float %6.6%
Short Ratio3.98
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)14.37%
Min EPS beat(2)12.81%
Max EPS beat(2)15.93%
EPS beat(4)4
Avg EPS beat(4)21.79%
Min EPS beat(4)0.93%
Max EPS beat(4)57.51%
EPS beat(8)8
Avg EPS beat(8)51.82%
EPS beat(12)11
Avg EPS beat(12)53.22%
EPS beat(16)13
Avg EPS beat(16)50.32%
Revenue beat(2)0
Avg Revenue beat(2)-2.3%
Min Revenue beat(2)-3.58%
Max Revenue beat(2)-1.03%
Revenue beat(4)1
Avg Revenue beat(4)-0.52%
Min Revenue beat(4)-3.58%
Max Revenue beat(4)2.78%
Revenue beat(8)5
Avg Revenue beat(8)0.93%
Revenue beat(12)7
Avg Revenue beat(12)0.54%
Revenue beat(16)9
Avg Revenue beat(16)0.41%
PT rev (1m)2.9%
PT rev (3m)-5.33%
EPS NQ rev (1m)0%
EPS NQ rev (3m)1.51%
EPS NY rev (1m)0.88%
EPS NY rev (3m)6.69%
Revenue NQ rev (1m)-0.31%
Revenue NQ rev (3m)-1.88%
Revenue NY rev (1m)-0.11%
Revenue NY rev (3m)-1.09%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 39.24 | ||
| Fwd PE | 33.83 | ||
| P/S | 10.1 | ||
| P/FCF | 29.62 | ||
| P/OCF | 27.39 | ||
| P/B | 10.8 | ||
| P/tB | 11.94 | ||
| EV/EBITDA | 50.36 |
EPS(TTM)0.46
EY2.55%
EPS(NY)0.53
Fwd EY2.96%
FCF(TTM)0.61
FCFY3.38%
OCF(TTM)0.66
OCFY3.65%
SpS1.79
BVpS1.67
TBVpS1.51
PEG (NY)2.08
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -19.17% | ||
| ROE | -36.96% | ||
| ROCE | 12.96% | ||
| ROIC | 10.23% | ||
| ROICexc | 926.92% | ||
| ROICexgc | N/A | ||
| OM | 14.16% | ||
| PM (TTM) | N/A | ||
| GM | 84.38% | ||
| FCFM | 34.12% |
ROA(3y)-9.14%
ROA(5y)-1.85%
ROE(3y)-54.72%
ROE(5y)N/A
ROIC(3y)7.06%
ROIC(5y)7.59%
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)8.94%
ROCE(5y)9.6%
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y10.9%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.66%
GM growth 5Y1.3%
F-Score5
Asset Turnover0.55
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Debt/EBITDA | 0 | ||
| Cap/Depr | 114.28% | ||
| Cap/Sales | 2.77% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 222.39% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.96 | ||
| Quick Ratio | 1.92 | ||
| Altman-Z | 8.02 |
F-Score5
WACC9.42%
ROIC/WACC1.09
Cap/Depr(3y)92.67%
Cap/Depr(5y)99.76%
Cap/Sales(3y)2.81%
Cap/Sales(5y)2.98%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)16.75%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%20%
EPS Next Y18.9%
EPS Next 2Y12.72%
EPS Next 3Y12.96%
EPS Next 5Y12.94%
Revenue 1Y (TTM)20.48%
Revenue growth 3Y17.68%
Revenue growth 5Y18.47%
Sales Q2Q%18.35%
Revenue Next Year17.63%
Revenue Next 2Y17.21%
Revenue Next 3Y17.04%
Revenue Next 5Y15.18%
EBIT growth 1Y23.19%
EBIT growth 3Y30.51%
EBIT growth 5YN/A
EBIT Next Year32.85%
EBIT Next 3Y23.1%
EBIT Next 5Y19.13%
FCF growth 1Y160.75%
FCF growth 3Y63.25%
FCF growth 5Y65.07%
OCF growth 1Y150.74%
OCF growth 3Y54.2%
OCF growth 5Y52.3%